Posted by Michael Wonder on 04 Jul 2016
Cancer drug move a victory
1 July 2016 - This week's announcement that PHARMAC is likely to fund Keytruda, a drug used for the treatment of melanoma, shows just how much ordinary people can achieve when they band together to make their voices heard.
PHARMAC issued a consultation document proposing to pay for Keytruda from September 1.
This follows its earlier decision to fund Keytruda rival Opdivo, starting today.
